ライフサイエンスコーパス: regulatory T-cell

1 CD4(+)T/Treg and CD8(+)T/Treg ratios (Treg, regulatory T cells).

2 and number of thymic and peripheral Foxp3(+) regulatory T cells.

3 on in the number and suppressive activity of regulatory T cells.

4 resenting cells to innate lymphoid cells and regulatory T cells.

5 ecome anergic or differentiate into Foxp3(+) regulatory T cells.

6 T cells but also increases the frequency of regulatory T cells.

7 y CD4 T cells and constrained in severity by regulatory T cells.

8 in vitro that mainly drives lesions, but not regulatory T cells.

9 amma production and expanding CD4(+)IL-10(+) regulatory T cells.

10 hey contribute to the generation of Th17 and regulatory T cells.

11 expanded Foxp3(+)CXCR5(+)PD-1(+) follicular regulatory T cells.

12 een groups receiving wild-type or NLRX1(-/-) regulatory T cells.

13 al tolerance and enhances differentiation of regulatory T cells.

14 mune-suppressive cytokine mainly produced by regulatory T cells.

15 ell numbers and supported differentiation of regulatory T cells.

16 lly contributed to the protective actions of regulatory T cells.

17 s aspect here, particularly as it relates to regulatory T cells.

18 are more similar to effector T cells than to regulatory T cells.

19 itors markedly suppress the proliferation of regulatory T cells.

20 pathogens by driving the differentiation of regulatory T cells.

21 uppression of proliferation and cytokines by regulatory T cells.

22 ly on cytotoxic T cells, T-helper cells, and regulatory T cells.

23 the effector subsets Th1, Th17, and induced regulatory T cells.

24 ity to differentiate into induced/peripheral regulatory T cells.

25 namely in transplantation, requires Foxp3(+) regulatory T cells.

26 nflammatory phenotype of Aspergillus-induced regulatory T-cells.

27 When regulatory T cells (2 x 106/mouse) were intravenously ad

28 in the aged environment can drive increased regulatory T cell accumulation.

29 tion was assessed based on helper T-cell and regulatory T-cell activation in mice.

30 ctivity by inhibiting CD8 T cells, enhancing regulatory T cell activity.

31 Moreover, OA-NO2 is capable of enhancing regulatory T-cell activity.

32 Altogether, our studies suggest that regulatory T cell adoptive transfer may alleviate thromb

33 Thus, regulatory T cell adoptive transfer may be useful as a c

34 Furthermore, regulatory T cell-afforded protection in the tPA-treated

35 crophage infiltration and higher presence of regulatory T cell after ischemia-reperfusion injury.

36 y primed antigen-specific forkhead box P3(+) regulatory T cells after in vitro coincubation with OVA/

37 expansion of forkhead box protein 3-positive regulatory T cells along with suppression of existing TH

38 , along with increased numbers of intestinal regulatory T cells and a higher production of luminal Ig

39 2s by co-stimulatory molecules such as ICOS, regulatory T cells and by compounds such as nicotine.

40 ia governing the balance between T helper 17/regulatory T cells and by regulating the formation of ef

41 expression of Gal-9 drives the expansion of regulatory T cells and contraction of effector T cells,

42 nsion of effector T cells and instability of regulatory T cells and contributes to T cell-dependent t

43 characterized by high levels of intrahepatic regulatory T cells and expression of inhibitory molecule

44 ning, but were accompanied by suppression of regulatory T cells and greater influx of activated CD8(+

45 d the cutaneous microenvironment by limiting regulatory T cells and IFN-gamma and inhibiting IL-10 pr

46 mechanism operating on the surface of human regulatory T cells and involving membrane protein GARP,

47 96 is essential for CD11c(+) cells to induce regulatory T cells and maintain gut homeostasis, illustr

48 ppressive cells at the tumor site, including regulatory T cells and myeloid-derived suppressor cells,

49 of profoundly decreased CTLA4 expression on regulatory T cells and probably contributes to autoimmun

50 se in the frequency of mTGFbeta(+)Foxp3(int) regulatory T cells and the persistence of CD206(+) macro

51 eregulated TGF-beta signaling with increased regulatory T cells and total FOXP3 expression.

52 function in peripheral CD4(+)CD25(+)FOXP3(+) regulatory T cells, and an impaired capacity of CD4(+)CD

53 on in naive T cells, helper Th17 T cells and regulatory T cells, and Ca(2+) signals mediated in T cel

54 ulations including hematopoietic stem cells, regulatory T cells, and facilitating cells are being con

55 -13(+) CD4 T cells, forkhead box P3-positive regulatory T cells, and IL-5(+) ILC2s.

56 ntrol TFH cell maturation, expand follicular regulatory T cells, and inhibit the TFH cell-mediated an

57 o autoimmunity by promoting anergy, inducing regulatory T cells, and inhibiting effector T cells.

58 lterations in the percentage of lymphocytes, regulatory T cells, and T-helper 1 and 17 cells, all maj

59 DK4/6 inhibitors both on tumour cells and on regulatory T cells are associated with reduced activity

60 apy mediated via the sustained generation of regulatory T cells arguably represents the ideal therape

61 Regulatory T cells attenuate development of asthma in wi

62 itical role for CREBBP/EP300 bromodomains in regulatory T cell biology.

63 lerance based on their impact on effector vs regulatory T-cell biology.

64 ociated with significantly higher numbers of regulatory T cells both in aortic sinus and spleen with

65 Suppression was not dependent on regulatory T cells, but was associated with increased in

66 Prior depletion of regulatory T cells by cyclophosphamide did not increase

67 of CD25 function abolished the induction of regulatory T cells by IL-10DCs, indicating a critical ro

68 e-positive thymocytes, CD4(+)CD8(-) T cells, regulatory T cells, CD4(+) T cell marker expression, lif

69 merism was associated with the generation of regulatory T cells (CD4CD25FoxP3).

70 Mechanistic studies demonstrated that regulatory T cells completely abolished the tPA-induced

71 demonstrated that soluble CD137 produced by regulatory T cells contributed to their autoimmune-suppr

72 c conditions are required to induce Foxp3(+) regulatory T cell conversion.

73 ivo hapten presentation, and forkhead box p3 regulatory T-cell conversion.

74 and specialized in forkhead box p3-positive regulatory T-cell conversion.

75 Regulatory T cell counts and % varied greatly among cGvH

76 n of naive T cells into T helper 17 cells or regulatory T cells creates subtype-specific enhancer-pro

77 induction increased numbers of lung and gut regulatory T cells, decreased lung TH2 responses, and am

78 ion-chemokine induction, T-cell stimulation, regulatory T cell depletion-was observed at all dose lev

79 The paracrine activity of regulatory T cell-derived TGF-beta1 contributes to immun

80 tion of self-reactive T cells and supporting regulatory T cell development.

81 Although the frequency of regulatory T cells did not change after treatment, there

82 RGC-32(-/-) mice have normal Th1, Th2, and regulatory T cell differentiation but show defective Th1

83 resented premature defects in mTEC-dependent regulatory T-cell differentiation and thymocyte maturati

84 inflamed islets and suggest that therapeutic regulatory T cells directly or indirectly regulate their

85 dinately represses genes controlling Th1 and regulatory T-cell fate.

86 No increase in regulatory T-cell frequency was evident in either group.

87 oups of patients, tolDCs were able to induce regulatory T cells from autologous naive CD4(+) T cells.

88 guished Vbeta2(+), Vbeta6(+) and Vbeta8.2(+) regulatory T cells from conventional T cells and also di

89 However, regulatory T cells from well-controlled patients had bet

90 gnificant increase in CD4CD25forkhead box P3 regulatory T cells (from 18% to 25%, P = 0.0002) and a c

91 FOXP3 is the transcription factor ruling regulatory T cell function and maintenance of peripheral

92 findings identify Batf as critical to tissue regulatory T cell function and suggest that polymorphism

93 ells into the spinal cord, without affecting regulatory T cell function.

94 ) T cell marker expression, lifespan, and Th/regulatory T cell function.

95 spleen of these mice likely due to a loss of regulatory T cell function.

96 atment combined with systemic elimination of regulatory T cells had potent synergistic effects agains

97 atory proteins CD80/CD86, signals needed for regulatory T cell homeostasis, are upregulated less on N

98 Cyclophosphamide depleted regulatory T cells in 24 of 27 patients receiving MVA-5T

99 (TH1/TH17), and decreased the production of regulatory T cells in an MLR.

100 -driven inflammatory responses and increased regulatory T cells in atherosclerotic arteries and lymph

101 In this study, we focus on the role of regulatory T cells in immunosuppression and show that re

102 Interestingly, the percentage of Foxp3+ regulatory T cells in liver transplant patients was stab

103 The number of circulating regulatory T cells in stroke patients was dramatically r

104 ntial role for lactationally transferred dam regulatory T cells in suppression of the ex vivo respons

105 PA treatment led to sustained suppression of regulatory T cells in the blood.

106 This study assessed the impact of regulatory T cells in the context of tPA-induced brain h

107 esults in a marked increase in the number of regulatory T cells in the ipsilateral limb.

108 R transgenic mice, we show that depletion of regulatory T cells in the setting of lymphatic injury re

109 t interferon gamma production by a subset of regulatory T cells in the tumor microenvironment trigger

110 leukin in the Adaptive Study of IL-2 Dose on Regulatory T Cells in Type 1 Diabetes (DILT1D), a single

111 tion of antigen-specific, inducible FoxP3(+) regulatory T cells in vitro and in vivo, and by reduced

112 G3)(+), CD49b(-), forkhead box P3 (Foxp3)(-) regulatory T cells in vitro, such that beta subunit of I

113 the blood-brain barrier protective effect of regulatory T cells in vitro.

114 rentiation and expansion of antigen-specific regulatory T cells in vivo.

115 Regulatory T cells % increased significantly above any o

116 ession of IL-33 promoted expansion of ST2(+) regulatory T cells, increased Th2 cytokine milieu, and i

117 ells, and CD70 limits T cell expansion via a regulatory T cell-independent mechanism that involves ca

118 ts and CD21(low) B cells, as well as TH2 and regulatory T cells, indicating a common disease pathogen

119 Emerging evidence reveals that a group of regulatory T cells, induced Tregs (iTregs), effectively

120 y in a mouse strain-dependent manner through regulatory T cell induction among lymphocytes in the int

121 the gut as well as loss of antigen-specific regulatory T cell induction in the mesenteric lymph node

122 e to allogeneic antigens, strongly promoting regulatory T-cell induction and inhibiting T-cell tumour

123 f the blood-brain barrier, we confirmed that regulatory T cells inhibited tPA-induced endothelial exp

124 ll development can occur via an RORgammat(-) regulatory T cell intermediate.

125 The number of IL-2-dependent FoxP3(+) regulatory T cells is increased in the peripheral blood

126 In vitro induced human regulatory T cells (iTregs) have demonstrated in vivo th

127 herapeutic group, the frequencies of induced regulatory T cells (iTregs: CD4(+)CD25(-)Fopx3(+)) and C

128 Aza increased the function of regulatory T cells, leading to enhanced suppressive acti

129 Treatment with islet Ag-specific regulatory T cells led to a marked decrease of Ccl5 and

130 related with shorter telomeres and increased regulatory T-cell levels.

131 of PD-L1, and contained within their stroma regulatory T cells, M2 (protumor) macrophages, and exhau

132 We show that a population of CD4CD127CD45RA Regulatory T cell may offer the best compromise between

133 Foxp3Treg cell was performed in DEpletion of REGulatory T cells mice at day 80 posttransplantation.

134 rgies and suggest that induction of Foxp3(-) regulatory T cells might be a useful strategy for tolera

135 hair follicle development, commensals induce regulatory T cell migration to the skin to ensure cutane

136 Regulatory T-cells, natural suppressor cells of the immu

137 ve failed to investigate the role of natural regulatory T cells (nTregs) on the mitigation of GvHD by

138 olism, as were cytokine secretion levels and regulatory T cell numbers.

139 CD8(+) T cells, but showed no differences in regulatory T-cell numbers relative to patients without I

140 tions in peripheral naive CD4(+) T cells and regulatory T cells occurred.

141 Notably, the development of Foxp3(+) regulatory T cells occurs normally in the absence of Bli

142 cific T cells; induction of antigen-specific regulatory T cells; or immune deviation in favor of TH1

143 , had a lower percentage of CD4+CD25hiFoxP3+ regulatory T cells (P < .01), but higher proportions of

144 ained immunotolerant CD3(+)/CD25(+)/FoxP3(+) regulatory T cells (p < 0.0001).

145 erferon (IFN-gamma)-secreting Th1 cells, and regulatory T cells play a protective role.

146 T cells and to increase their sensitivity to regulatory T-cell polarization signals, both processes r

147 cells but not with the CD4(+)CD25(+)Foxp3(+) regulatory T cell populations in the tumor.

148 elper type 2 cell (Th2 cell), Th17 cell, and regulatory T cell populations while suppressing Th1 cell

149 aired effector T cell potential but enhanced regulatory T cell potential.

150 ces in the percentages of immune-suppressive regulatory T cells, pro-inflammatory Th17 cells, or thei

151 2Ralpha, BiG had no impact on IL-2-dependent regulatory T cell proliferation.

152 y T cells in immunosuppression and show that regulatory T-cell proliferation in tissues distal to sit

153 histamine release and casein-specific CD4(+) regulatory T-cell proliferation.

154 of oral tolerance by suppressing peripheral regulatory T cell (pTreg) conversion and promoting TH1 i

155 an elevated effector CD8(+) T-cell to CD4(+) regulatory T-cell ratio (IFNgamma(+)CD8(+):Treg).

156 ion yet retained expression of IFN-gamma and regulatory T cell-recruiting chemokines.

157 hemagglutinin (HA) which potentially enhance regulatory T cell response due to conservation with the

158 rleukin-17/21 inhibition, kinase inhibition, regulatory T-cell restoration, and CSF-1 inhibition.

159 dependent IL-10 production by progranulin in regulatory T cells restrains inflammatory arthritis.

160 TCR signals accompany both conventional and regulatory T cell selection.

161 Regulatory T cell-specific demethylation region (TSDR) d

162 y T helper (TH17) cell state and away from a regulatory T cell state.

163 We found that conventional and regulatory T cell subsets in the thymus of neonates and

164 LRBA-sufficient but not LRBA-deficient regulatory T cells suppressed in vitro TFH cell differen

165 a-producing T cells in the spleen as well as regulatory T cell suppression.

166 The regulatory T cell (T reg cell) T cell receptor (TCR) rep

167 er, simultaneous expansion of CD4(+)Foxp3(+) regulatory T cells (T reg cells) impedes protective resp

168 Oral administration of Ag induces regulatory T cells that express latent membrane-bound TG

169 ependent and is mediated by the induction of regulatory T cells that share a similar transcriptional

170 cular regulatory (Tfr) cells are a subset of regulatory T cells that suppress T follicular helper (Tf

171 h autophagy favours the lineage stability of regulatory T cells, the contribution of autophagy to the

172 therapeutics that can rebalance the ratio of regulatory T cells to effectors are a relevant issue.

173 eclinical models highlights the potential of regulatory T cells to restore tolerance.

174 sociated with higher IL-10 concentration and regulatory T cell-to-leukocyte ratio in RIPK3 knockout m

175 Type 1 regulatory T cells (Tr1 cells) are induced by interleuki

176 tigate the therapeutic potential of adoptive regulatory T cell transfer against tPA-induced haemorrha

177 ayed tPA after stroke, but were mitigated by regulatory T cell transfer.

178 but not conventional CD4(+) T-cell subsets [regulatory T cell (Treg) and conventional T cell (Tconv)

179 own whether these factors are needed for the regulatory T cell (Treg) arm of MHC class II responses.

180 receptor under the Foxp3 promoter, transient regulatory T cell (Treg) depletion results in long-lasti

181 ects in CD4 T cell gene expression and Foxp3 regulatory T cell (Treg) differentiation.

182 terferon regulatory factor 4 (IRF4) promotes regulatory T cell (Treg) generation by enhancing express

183 the modulatory capacity of G-Neutrophils on regulatory T cell (Treg) generation.

184 sion of CTL killing by CD4(+)CD25(+)Foxp3(+) regulatory T cell (Treg) is in part mediated by TGFbeta-

185 tosis resulting mostly from inherent reduced regulatory T cell (Treg) numbers.

186 regulatory T (TFR) cells are a newly defined regulatory T cell (Treg) subset that suppresses follicul

187 Regulatory T cell (Treg) therapy using recipient-derived

188 L4 deficiency compromised the development of regulatory T cells (Treg cells) and resulted in a substa

189 balance in the lineages of immunosuppressive regulatory T cells (Treg cells) and the inflammatory TH1

190 The current study identifies CCR8(+) regulatory T cells (Treg cells) as drivers of immunosupp

191 NKG2D, a decrease in CD4(+) CD25(+) FOXP3(+) regulatory T cells (Treg cells) as well as CD25(+) CD4(+

192 sgenic mice are predominantly CD4(+)Foxp3(+) regulatory T cells (Treg cells) expressing tolerogenic c

193 Regulatory T cells (Treg cells) have a pivotal role in t

194 on, and increased the proportion of Foxp3(+) regulatory T cells (Treg cells) in mice.

195 Through the use of regulatory T cells (Treg cells) induced by transforming

196 Foxp3(+) regulatory T cells (Treg cells) modulate the immune syst

197 Regulatory T cells (Treg cells) perform suppressive func

198 Live regulatory T cells (Treg cells) suppress antitumor immun

199 identified as a key transcription factor for regulatory T cells (Treg cells), was also expressed in m

200 riptional signature and functional facets of regulatory T cells (Treg cells).

201 Approaches that enhance the function of regulatory T cells (Treg) and dampen effector T cells ca

202 Regulatory T cells (Treg) attenuate dendritic cell (DC)

203 atic ILC2s but also expanded CD4(+) Foxp3(+) regulatory T cells (Treg) expressing the IL-33 receptor

204 Elevated numbers of regulatory T cells (Treg) in patient tumors are known to

205 We report that regulatory T cells (Treg) promote oligodendrocyte differ

206 However, PI3Kdelta mutation also dampens regulatory T cells (Treg).

207 aive CD4(+) T cells into functional Foxp3(+) regulatory T cells (Treg).

208 via targeting IL-17 secreting Th17 cells and regulatory T cells (Treg).

209 (AAD), associated with induction of Foxp3(+) regulatory T cells (Treg).

210 together with increased Th1, Th2, Th17, and regulatory T-cell (Treg) CD4(+) subsets; (2) significant

211 are resistant to VL, due in part to impaired regulatory T-cell (Treg) expansion.

212 Direct mutation in CTLA-4 leads to defective regulatory T-cell (Treg) function associated with impair

213 pulation of immunosuppressive T-cells called regulatory T-cells (Treg) regulates proliferation of imm

214 Regulatory T cells (Tregs) adopt specialized phenotypes

215 on of the Foxp3 gene leads to the absence of regulatory T cells (Tregs) and a fatal systemic autoimmu

216 Significantly, U. parvum decreased regulatory T cells (Tregs) and activated interferon gamm

217 lergy season by increasing the percentage of regulatory T cells (Tregs) and inducing tolerance.The ob

218 AE) as a result of an increase of protective regulatory T cells (Tregs) and reduction of encephalitog

219 constitutively expressed on CD4(+) Foxp3(+) regulatory T cells (Tregs) and TNF-TNFR2 interaction is

220 Regulatory T cells (Tregs) are a barrier to anti-tumor i

221 FoxP3(+) regulatory T cells (Tregs) are a central element of immu

222 Regulatory T cells (Tregs) are emerging as an essential

223 Foxp3-expressing regulatory T cells (Tregs) are essential regulators of i

224 Regulatory T cells (Tregs) are essential to suppress unw

225 CD4(+)Foxp3(+) regulatory T cells (Tregs) are indispensable negative re

226 feration, the distinct metabolic features of regulatory T cells (Tregs) are less well established.

227 Regulatory T cells (Tregs) are required to establish imm

228 Therapeutic CD4(+)Foxp3(+) natural regulatory T cells (Tregs) can control experimental graf

229 Although regulatory T cells (Tregs) can inhibit GC reactions, Tre

230 e demonstrated that the adoptive transfer of regulatory T cells (Tregs) can mediate the inflammation

231 Understanding functions of Foxp3(+) regulatory T cells (Tregs) during allergic airway inflam

232 the endocrine regulation of conventional and regulatory T cells (Tregs) during reproduction.

233 We found regulatory T cells (Tregs) enriched in the skin of toler

234 GVHD risk and appears to initially depend on regulatory T cells (Tregs) followed by gradual, presumab

235 Injection of regulatory T cells (Tregs) followed by sensitization wit

236 es might be harnessed to selectively promote regulatory T cells (Tregs) for therapies in autoimmunity

237 to their ability to suppress effector cells, regulatory T cells (Tregs) have been proposed as a cellu

238 Regulatory T cells (Tregs) in skin preferentially locali

239 Regulatory T cells (Tregs) induced during autoimmunity o

240 Use of a patient's own suppressive regulatory T cells (Tregs) is an attractive biologic app

241 ater severity occurring when the activity of regulatory T cells (Tregs) is compromised.

242 ecent studies showed that the dysfunction of regulatory T cells (Tregs) is directly linked to the ini

243 tivation of T cells and their suppression by regulatory T cells (Tregs) is dysregulated in autoimmune

244 The TCR repertoire of regulatory T cells (Tregs) is highly diverse.

245 Regulatory T cells (Tregs) play a pivotal role in the in

246 Regulatory T cells (Tregs) play an important role in the

247 CD4(+)Foxp3(+) regulatory T cells (Tregs) protect the kidney during AKI

248 Human regulatory T cells (Tregs) suppress other T cells by con

249 Regulatory T cells (Tregs) suppress T-cell immune activa

250 naive and memory T cells, and the ability of regulatory T cells (Tregs) to prevent responses.

251 Additionally, CD4+ Foxp3+ regulatory T cells (Tregs) uptake FA at a higher rate th

252 Regulatory T cells (Tregs) use a distinct TCR repertoire

253 Recently, regulatory T cells (Tregs) were described as necessary f

254 ng tumor-associated macrophages and FoxP3(+) regulatory T cells (Tregs) within the tumor microenviron

255 s (myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs), and programmed death-1 (PD-1

256 iously generated engineered antigen-specific regulatory T cells (Tregs), created by transduction of a

257 unosuppression in association with increased regulatory T cells (Tregs), making this transcription fa

258 results in expansion of Foxp3(+) and LAP(+) regulatory T cells (Tregs), suggesting oral delivery of

259 metry, we found that the TME was enriched in regulatory T cells (Tregs), tissue resident memory CD8(+

260 actor that drives lineage differentiation of regulatory T cells (Tregs), was thought to imprint a uni

261 articles is known to induce antigen-specific regulatory T cells (Tregs), we adapted this approach to

262 a subset of these cells into CD4+CD25+FoxP3+ regulatory T cells (Tregs).

263 s of naturally suppressive allergen-specific regulatory T cells (Tregs).

264 ther short-chain fatty acids (SCFAs), induce regulatory T cells (Tregs).

265 al are either deleted or differentiated into regulatory T cells (Tregs).

266 the suppressive function of therapy-induced regulatory T cells (Tregs).

267 n while promoting the generation of Foxp3(+) regulatory T cells (Tregs).

268 ion of the key transcription factor FoxP3 in regulatory T cells (Tregs).

269 ansion of donor Foxp3(+) naturally occurring regulatory T cells (Tregs).

270 ong anti-alpha-synuclein antibody titers and regulatory T cells (Tregs).

271 l role in the expansion and function of CD4+ regulatory T cells (Tregs).

272 by controlling the balance between Th17 and regulatory T cells (Tregs).

273 farm-milk exposure was partially mediated by regulatory T cells (Tregs).

274 d fail to produce effective immuno-competent regulatory T cells (Tregs).

275 ss well known, especially the role of CD4(+) regulatory T cells (Tregs).

276 atory capacity due to increased induction of regulatory T cells (Tregs).

277 Regulatory T-cells (Tregs) play a pivotal role in mainta

278 by increasing the stability and function of regulatory T cells using the DNA methyltransferase inhib

279 ction of peripheral T-cell subsets including regulatory T cells was observed after the first dose of

280 ugh most tolerance-inducing regimens rely on regulatory T cells, we found that induction of tolerance

281 o antitumor efficacy and intratumoral CD8(+)/regulatory T cells were also observed.

282 Regulatory T cells were sorted according to expression o

283 Mesenteric lymph node CD4(+) FoxP3(+) regulatory T cells were subjected to flow cytometric qua

284 as the frequency and suppressive capacity of regulatory T cells were unaffected.

285 T cells, which share phenotypic markers with regulatory T cells, were enriched in SIV DNA in blood, l

286 ic cells, Th2 cells, follicular T cells, and regulatory T cells, where IL-33 influences the developme

287 tolerance to atherogenic peptides increases regulatory T cells which activate M2 macrophages, preven

288 ATP citrate lyase, induced the depletion of regulatory T cells (which dampen anticancer immunity) fr

289 We previously reported that regulatory T cells, which function to suppress excessive

290 or immune cells, and decreased the number of regulatory T cells, which in turn killed a larger number

291 This in turn promotes the activation of regulatory T cells while impairing Th1 response; however

292 RPS19 promotes generation of regulatory T cells while reducing infiltration of CD8(+)

293 rogram inducing the accumulation of Foxp3(+) regulatory T cells, while decreasing the levels of Th17

294 vation of T-helper 17 cell and inhibition of regulatory T cell with attendant inflammation.

295 n conclusion, our results suggest a role for regulatory T-cells with a pro-inflammatory TH17-like phe

296 We also demonstrate that these regulatory T-cells with a pro-inflammatory TH17-like phe

297 onstrates that Aspergillus fumigatus induces regulatory T-cells with a TH17-like phenotype.

298 ly, this reduction resulted in a decrease in regulatory T cells, with an increase in myelin basic pro

299 on was paralleled by an increase in FoxP3(+) regulatory T cells within the cellular infiltrates aroun

300 ually repopulated the numbers of circulating regulatory T cells within the first 7 days after stroke,